Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3058% above fair value
$18.55−1.60 (-7.94%)
Close on Nov 20, 2026Market cap $1.79BP/E –Yield –
Fortrea shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Fortrea's shares outstanding was 101M at Sep 30, 2026. For fiscal 2024 it was 90M, up 0.8% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 90M | +0.8% |
| FY2023 | Dec 31, 2023 | 89M | 0.0% |
| FY2022 | Dec 31, 2022 | 89M | 0.0% |
| FY2021 | Dec 31, 2021 | 89M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 101M | +11.7% |
| Q2 FY2026 | Jun 30, 2026 | 95M | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | 94M | +4.2% |
| Q3 FY2025 | Sep 30, 2025 | 91M | +1.8% |
| Q2 FY2025 | Jun 30, 2025 | 91M | +1.3% |
| Q1 FY2025 | Mar 31, 2025 | 90M | +1.0% |
| Q4 FY2024 | Dec 31, 2024 | 90M | +1.8% |
| Q3 FY2024 | Sep 30, 2024 | 90M | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | 89M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | 89M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | 88M | -0.7% |
| Q3 FY2023 | Sep 30, 2023 | 89M | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | 89M | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | 89M | – |
| Q4 FY2022 | Dec 31, 2022 | 89M | – |
| Q3 FY2022 | Sep 30, 2022 | 89M | – |
| Q2 FY2022 | Jun 30, 2022 | 89M | – |
See a number that looks wrong?